Pacific trade deal adds to U.S. price quandary for biotech drugs
October 05, 2015 at 16:51 PM EDT
NEW YORK/ATLANTA, Oct 5 (Reuters) - The Pacific trade deal agreed on Monday, which grants biotechnology drug producers less protection than offered by the United States, could put more downward pressures on the costly drugs' pricing in the industry's most lucrative market.